ArticlePeerJ2020

Engineering of HN3 increases the tumor targeting specificity of exosomes and upgrade the anti-tumor effect of sorafenib on HuH-7 cells.

Cong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.